Literature DB >> 14500494

The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Warren L Simmons1, Kevin Dybvig.   

Abstract

The variable surface antigens (Vsa) of the murine respiratory pathogen Mycoplasma pulmonis are associated with the virulence of the microorganism in the lung. In strain UAB CT, the antigens consist of an N-terminal region that is combined with one of seven different C-terminal variable regions comprised of tandem repeats. M. pulmonis producing a VsaA protein with about 40 tandem repeats (R40) does not adhere to red blood cells or polystyrene. Strains that produce VsaH contain a short C-terminal region that lacks tandem repeats and adhere to red blood cells and plastic. We isolated and analyzed M. pulmonis strain CT variants (CT182 and derivatives) that produced a VsaA protein with only three tandem repeats (R3). These variants adhered to plastic and red blood cells similarly to the VsaH-producing strain. When the R3-producing CT182 strain or the VsaH-producing strains were incubated with normal guinea pig serum, they were efficiently killed. Killing was abolished when the serum was heat inactivated. In contrast, the M. pulmonis strains that produced VsaA R40 were highly resistant to complement killing. CT182R3 variants that survived the complement killing reactions all produced the R40 form of VsaA and were resistant to complement killing. VsaA R40 is the first mycoplasmal protein shown to be associated with resistance to complement. As both VsaH and VsaA can mediate adherence to plastic, cytadherence, and susceptibility to complement, we propose that Vsa modulates these phenotypes by nonspecific interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500494      PMCID: PMC201092          DOI: 10.1128/IAI.71.10.5733-5738.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.

Authors:  B Bhugra; L L Voelker; N Zou; H Yu; K Dybvig
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

Review 4.  Mycoplasma pneumoniae cytadherence: organization and assembly of the attachment organelle.

Authors:  D C Krause
Journal:  Trends Microbiol       Date:  1998-01       Impact factor: 17.079

5.  Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59).

Authors:  R Rautemaa; G A Jarvis; P Marnila; S Meri
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 6.  Role of the complement system in pulmonary disorders.

Authors:  J F Regal
Journal:  Immunopharmacology       Date:  1997-12

7.  Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis.

Authors:  K Dybvig; C T French; L L Voelker
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

8.  Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.

Authors:  C Citti; M F Kim; K S Wise
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

9.  Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation.

Authors:  W L Simmons; C Zuhua; J I Glass; J W Simecka; G H Cassell; H L Watson
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

10.  Roles of innate and adaptive immunity in respiratory mycoplasmosis.

Authors:  S C Cartner; J R Lindsey; J Gibbs-Erwin; G H Cassell; J W Simecka
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  20 in total

1.  Fewer essential genes in mycoplasmas than previous studies suggest.

Authors:  Kevin Dybvig; Ping Lao; David S Jordan; Warren L Simmons
Journal:  FEMS Microbiol Lett       Date:  2010-08-16       Impact factor: 2.742

Review 2.  Interactions between mycoplasma lipid-associated membrane proteins and the host cells.

Authors:  Xiao-xing You; Yan-hua Zeng; Yi-mou Wu
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

3.  Association of a major protein antigen of Mycoplasma arthritidis with virulence.

Authors:  A-H T Tu; B Clapper; T R Schoeb; A Elgavish; J Zhang; L Liu; H Yu; K Dybvig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

5.  Large-scale transposon mutagenesis of Mycoplasma pulmonis.

Authors:  Christopher T French; Ping Lao; Ann E Loraine; Brian T Matthews; Huilan Yu; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2008-04-28       Impact factor: 3.501

6.  Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.

Authors:  Jeffrey R Bolland; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-04-10       Impact factor: 2.742

7.  A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.

Authors:  Warren L Simmons; Jeffrey R Bolland; James M Daubenspeck; Kevin Dybvig
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

8.  Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms.

Authors:  Warren L Simmons; James M Daubenspeck; John D Osborne; Mitchell F Balish; Ken B Waites; Kevin Dybvig
Journal:  Microbiology       Date:  2013-02-14       Impact factor: 2.777

9.  Mycoplasma polysaccharide protects against complement.

Authors:  Jeffrey R Bolland; Warren L Simmons; James M Daubenspeck; Kevin Dybvig
Journal:  Microbiology       Date:  2012-04-13       Impact factor: 2.777

10.  The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Authors:  Brandon M Shaw; Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.